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Twenty-six families with keratinopathic ichthyoses (epi-
dermolytic ichthyosis, superficial epidermolytic ichthyo-
sis or congenital reticular ichthyosiform erythroderma) 
were studied. Epidermolytic ichthyosis is caused by mu-
tations in the genes KRT1 or KRT10, mutations in the 
gene KRT2 lead to superficial epidermolytic ichthyosis, 
and congenital reticular ichthyosiform erythroderma is 
caused by frameshift mutations in the genes KRT10 or 
KRT1, which lead to the phenomenon of revertant mo-
saicism. In this study mutations were found in KRT1, 
KRT2 and KRT10, including 8 mutations that are novel 
pathogenic variants. We report here the first case of a 
patient with congenital reticular ichthyosiform erythro-
derma carrying a mutation in KRT10 that does not lead 
to an arginine-rich reading frame. Novel clinical features 
found in patients with congenital reticular ichthyosiform 
erythroderma are described, such as mental retarda-
tion, spasticity, facial dysmorphisms, symblepharon and 
malposition of the 4th toe. Key words: epidermolytic icht-
hyosis; congenital reticular ichthyosiform erythroderma; 
KRT1; KRT2; KRT10.
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Keratinopathic ichthyoses (KPI) are defined as inherited 
skin disorders caused by mutations in keratin genes. 
These genes encode keratin proteins, which form part 
of the cytoskeleton and are important for normal tissue 
structure and function. The KPI classification includes 
epidermolytic ichthyosis (EI, OMIM #113800), superfi-
cial epidermolytic ichthyosis (SEI, OMIM #146800) and 
congenital reticular ichthyosiform erythroderma (CRIE, 
OMIM #609165) (1).
EI, formerly known as epidermolytic hyperkeratosis 
or bullous congenital ichthyosiform erythroderma of 
Brocq (BCIE), is characterized by diffuse erythroderma 
and blistering at birth. With increasing age, blistering 
and erythroderma improve and are replaced by progres-
sive hyperkeratosis. EI is usually inherited in an auto-
somal dominant manner and is caused by heterozygous 
mutations in the keratin genes KRT1 (OMIM *139350) 
or KRT10 (OMIM *148080). Approximately 50% of 
cases of EI occur de novo due to spontaneous mutations 
(2). Mutations in KRT1 usually lead to a phenotype 
with much more severe palmoplantar hyperkeratosis 
than those in KRT10. In rare cases EI is inherited in an 
autosomal recessive manner and has been described in 
consanguineous families with homozygous mutations 
in KRT10 (3–8).
CRIE, also known as ichtyosis en confetti, can be 
caused by heterozygous mutations in KRT10 (9) or, 
as has been shown recently, in KRT1 (10). At birth it 
may be difficult to distinguish this phenotype from a 
severe congenital ichthyosiform erythroderma (CIE), 
because CRIE is not associated with blistering skin. 
Small confetti-like spots of almost normal skin appear 
in childhood and increase in size and number with time. 
They can be explained by mitotic recombination and 
a revertant mosaicism from clonal expansion of a cor-
rected stem cell (9). These reversions seem to develop 
significantly later in life (at approximately 20 years of 
age) in CRIE associated with a KRT1 mutation (10). 
SEI, in the past known as ichthyosis bullosa of 
Siemens (IBS), is due to heterozygous mutations in 
KRT2 (OMIM *600194). Clinical findings are similar 
to those of EI, but the phenotype is generally milder 
and can be quite variable in severity (11, 12). Patients 
with SEI show generalized erythroderma and blistering 
at birth. Symptoms usually improve with age. Later 
in life, erythroderma regresses almost completely and 
keratotic lichenification may concentrate on the joint 
areas of arms and legs typically showing the so-called 
“Mauserung phenomenon”.
Expanding the Clinical and Genetic Spectrum of KRT1, KRT2 and 
KRT10 Mutations in Keratinopathic Ichthyosis
Alrun HOTZ1, Vinzenz OJI2, Emmanuelle BOURRAT3, Nathalie JONCA4, Juliette MAZEREEUW-HAUTIER4, Regina C. BETZ5, 
Ulrike BLUME-PEYTAVI6, Karola STIELER6, Fanny MORICE-PICARD7, Ines SCHÖNBUCHNER8, Susanne MARKUS9, Nina 
SCHLIPF1 and Judith FISCHER1
1Institute of Human Genetics, University Medical Center Freiburg, Freiburg, 2Department of Dermatology, University Hospital Münster, Münster, Germany, 
3Centre de Reference des Genodermatoses, Hôpital Saint-Louis, Paris, 4UMR 5165/U1056 ‘Unité de Différenciation Epidermique et Autoimmunité Rhu-
matoïde’, Hôpital Purpan, Toulouse, France, 5Institute of Human Genetics, University of Bonn, Bonn, 6Department of Dermatology and Allergy, Charité-
Universitätsmedizin Berlin, Berlin, Germany, 7Service de Dermatologie et Dermatologie Pédiatrique, Centre de Référence pour les Maladies Rares de la 
Peau, CHU de Bordeaux, Bordeaux, France, 8Department of Human Genetics, University Hospital Regensburg, and 9Competence Center for Human Genetics, 
Gynaecology and Laboratory Medicine, Regensburg, Germany
474 A. Hotz et al.
The clinical and genetic features of a series of 26 
families with KPI, including 8 novel mutations, are 
described here.
MATERIALS AND METHODS
Informed consent was obtained from all patients. Genomic DNA 
was isolated from peripheral blood leucocytes by standard me-
thods. For mutation analysis, all coding exons and adjacent splice 
sites of the genes KRT1, KRT2 and KRT10 were amplified by po-
lymerase chain reaction (PCR) using exon-specific primer pairs, 
which were established in our laboratory. These primers are listed 
in Table SI1. Automated DNA sequencing analysis was performed 
on an ABI 3500 DNA Sequencer (Applied Biosystems, Foster 
City, CA, USA). In some patients next generation sequencing 
was performed and the detected mutations were validated using 
direct Sanger sequencing. A Nextera® Rapid Capture Enrichment 
kit (Illumina, San Diego, CA, USA) was used for enrichment 
of the sequences and performed sequencing analysis onto the 
Illumina MiSeq instrument (Illumina, San Diego, CA, USA).
Reference sequences NM_006121.3 for KRT1, NM_000423.2 
for KRT2 and NM_000421.3 for KRT10 were used. All novel 
mutations detected are not referenced as single nucleotide po-
lymorphisms (SNPs) and were not found in the HGMD Profes-
sional Database (www.hgmd.cf.ac.uk), 1000 Genomes Database 
(http://www.1000genomes.org) or in the Exome Aggregation 
Consortium (http://exac.broadinstitute.org). They are predicted 
to be disease-causing in Mutation Taster (http://www.muta-
tiontaster.org/) and Poly-Phen 2 (http://genetics.bwh.harvard.
edu/pph2/). For splice variants splice prediction tools, such as 
Human Splicing Finder (http://www.umd.be/HSF/), were used.
Formalin-fixed paraffin-embedded skin biopsies were used 
for immunofluorescence staining. Deparaffinized 5 µm-thick 
sections were blocked with phosphate-buffered saline (PBS) 
containing 5% normal goat serum and incubated with the mouse 
monoclonal anti-human K10 primary antibody (LH2, Santa Cruz 
Biotechnology, Dallas, TX, USA) diluted 1:800 for 1 h at 37°C. 
After incubation with the secondary antibody Alexa-Fluor®-488-
conjugated goat anti-mouse IgG (Life Technologies, Paisley, 
UK) diluted 1:1000, nuclei were stained with 4’-6’-diamidino-
2-phenylindole (DAPI; Sigma-Aldrich, St Louis, MO, USA). 
The slides were mounted with Mowiol 4-88 (Merck Millipore, 
Darmstadt, Germany) and images were obtained using a Nikon 
Eclipse 80i microscope equipped with a Nikon DXM 1200C 
digital camera and NIS image analysis software. 
RESULTS
Twenty-six families were studied: 4 with SEI, 16 with 
EI and 6 with CRIE, in whom heterozygous mutations 
were found in KRT2, KRT1 or KRT10, respectively. 
Eight mutations are novel pathogenic sequence va-
riants. The patients, their clinical and histological 
findings and the mutations identified are summarized 
in Table SII1.
Superficial epidermolytic ichthyosis
Heterozygous mutations were identified in the KRT2 
gene in 7 patients from 4 families with SEI (Table SII1)2. 
A novel mutation, c.1438T>C, p.Tyr480His, was iden-
tified. This mutation has not been described previously, 
is located in a highly conserved region and is therefore 
predicted to be disease causing. The mutation was found 
in a 9-year-old boy (patient P2-2) and in his father (pa-
tient P2-1). The boy presented mild hyperkeratosis, and 
bullous lesions appeared only in the warm season (Fig. 
1A–C). The father presented the same mild hyperke-
ratosis; his bullous phenotype disappeared at puberty. 
Epidermolytic ichthyosis
The phenotypes of the patients with EI in this study 
confirm the observation that mutations in KRT1 usually 
lead to more severe palmoplantar hyperkeratosis than 
KRT10 mutations (Table SII1)3. For example patient 
P5 developed severe palmoplantar keratoderma (PPK) 
and generalized ichthyosis that was pronounced at the 
extensor side of the joints (Fig. 2A–D). 
In patient P10 the novel KRT1 mutation c.1752dupT, 
p.Gly585Trpfs69* was discovered. The patient was 
born with ichthyosis and developed moderate PPK 
and generalized ichthyosis that was pronounced at the 
extensor side of the joints (Fig. 2E–H). The mutation 
leads to an elongated protein (Fig. S11). 
An additional 9 families with EI and without PPK show 
mutations in exon 1 of the KRT10 gene [Table SII1]4. 
One patient with EI (patient P20) carried the novel 
mutation c.1345T>C, p.Tyr449His in exon 6 of the 
KRT1 gene. Many other mutations in this 2B domain 
of the K10 protein have been reported. Patient P20 
showed typical EI, no special features were observed. 
Similar mutations at this residue with other amino acid 
changes have been described (7, 23).
Congenital reticular ichthyosiform erythroderma
Six patients were affected with CRIE, 5 of them 
exhibited novel mutations in KRT10 (Table SII1). In 
patient P23 the splice site mutation c.1374-1G>C, 
1http://www.medicaljournals.se/acta/content/?doi=10.2340/00015555-2299
2The mutations c.558C>A, p.Asn186Lys (patient P1) and c.1459G>A, 
p.Glu487Lys (family 3 (patients P3-1, P3-2 and P3-3) and patient P4) have 
been described previously (12, 13).
3The mutations c.698C>T, p.Ser233Leu (14) in patient P6, c.1436T>C, 
p.Ile479Thr (15) in family 8 (P8-1, P8-2), c.1434G>T, p.Glu478Asp (16–18) 
in patient P7, c.1468G>A, p.Glu490Lys (7) in patient P9 and c.563A>G, 
p.Asn188Ser (19) in patient P5 have been described previously.
4Six patients have the mutation c.467G>A, p.Arg156His (20) and 1 patient 
has the mutation c.467G>T, p.Arg156Leu (21). This suggests that codon 
156 is a hotspot for mutations in EI. The mutation c.482T>C, p.Leu161Ser 
in patients P18 and P19 has been previously reported in Bygum et al. (22), 
who described 2 patients with this mutation. In family 12, the mother (P12-2) 
of the affected boy (P12-1) carries the mutation p.Arg156His in a mosaic 
state; approximately 22% of the leucocytes are affected. This resulted in 
a relatively mild phenotype in the mother. She had bullous ichthyosiform 
erythroderma at birth, but fewer blisters than her son. At present she shows 
blistering and hyperkeratosis only after mechanical stress. Epidermolytic 
naevi have not been observed in the mother.
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p.Ser458Argfs*120 was identified in KRT10, which has 
been described previously in 2 cases with CRIE (24, 
25)5. This patient shows CRIE with PPK and ectropion 
as well as several additional extracutaneous features 
such as severe mental retardation, malposition of the 4th 
toe, short stature, facial dysmorphism, spasticity, age-
nesia of nipples, thick hair and onychodystrophy (Fig. 
3A). Slight mental retardation has also been found in 
patient P25 with CRIE and PPK, who carries the novel 
mutation c.1544delG in KRT10. This patient shows 
similar features to patient P23, such as malposition of 
the 4th  toe, short stature and facial dysmorphism (Fig. 
3B–E). It is interesting that the mutation c.1544delG 
in patient P25 leads to an alanine-rich reading frame 
(Fig. S11).
Immunofluorescence labelling for K10 in ichthyotic 
skin from patient P23 showed a weak and irregular 
cytoplasmic staining with a bright nuclear staining, 
consistent with the characteristic K10 mislocalization 
previously described in CRIE (9, 24, 26). In contrast, 
this nuclear staining, as well as vacuolization in the 
suprabasal epidermis layers is no longer visible in the 
confetti-like spots on the skin, consistent with the re-
vertant phenotype (Fig. 3F–H). 
Additional splice site mutations in the same splice site 
region described above, the mutations c.1374-1G>A, 
Fig. 1. (A–C) Clinical example of 9-year-old patient P2-2 with superficial epidermolytic ichthyosis (SEI). The patient carries the novel mutation 
c.1438T>C, p.Tyr480His in KRT2.
Fig. 2. Clinical examples of patients with epidermolytic ichthyosis (EI) and mutations in KRT1: patient P5 shows EI with (A–C) severe palmoplantar 
keratoderma (PPK) and (D) hyperkeratosis on the elbows. (E–H) A milder phenotype is presented in patient P10 with moderate PPK. The patient has the 
novel mutation c.1752dupT, p.Gly585Trpfs69*.
5 The patient described by Diociaiuti et al. (24) exhibited CRIE with PPK, mild 
ectropion, pruritus, hypertrichosis, ear deformity and growth retardation, but 
no mental retardation. The patient reported by Spoerri et al. (25) exhibited a 
similar phenotype with CRIE and hypertrichosis, hyperpigmentation of healthy 
spots, hypoplasia of mammillae, ear deformity, ectropion and strabismus.
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c.1374-2A>G and c.1374-2delA, have been described 
by Choate et al. (9) in patients with CRIE6.
Furthermore, 2 novel insertion mutations were disco-
vered in KRT10, c.1411_1412insA in patient P24 and 
c.1544dupG in P267. Patient P26 shows CRIE and hy-
pertrichosis, but no other extracutaneous malformations 
have been described. The phenotype of patient P24 is 
more severe; she was born with a collodion membrane 
and developed a highly inflammatory ichthyosis inclu-
ding alopecia totalis. She has severe growth retardation 
and partially blocked joints due to constrictive skin. The 
first spot was noted at the age of 2 years. 
DISCUSSION
In this study, 26 families with SEI, EI and CRIE who 
carry mutations in KRT1, KRT2 or KRT10 were analy-
sed, thereby expanding the genotypic and phenotypic 
spectrum of these diseases.
It is notable that previously reported KRT10 mutations 
in patients with autosomal dominant EI are substitutions 
of a single base in exons 1 or 6, whereas mutations in 
Fig. 3. Clinical examples of patients with congenital reticular ichthyosiform erythroderma (CRIE) who carries mutations in KRT10: (A) confetti-like spots 
in patient P23. Patient P25 carries the novel mutation c.1544delG,p.Gly515Alafs*110 and shows (C) confetti-like spots, (B, D, E) shortened fingers and 
toes and malposition of the 4th toe and (D) syndactyly of the 2nd and 3rd toes. (F, G) Immunofluorescence labelling for K10 (green) in patient P23 shows 
a weak heterogeneous cytoplasmic staining and a bright nuclear staining in lesional skin contrasting with (H) the near normal staining in confetti-like 
spot non-lesional skin. In (F) and (H), nuclei are counterstained with 4′,6-diamidino-2-phenylindole (DAPI) (blue).
6All of these splice site mutations lead to an 8-base deletion in the cDNA with 
frameshift leading to an arginine-rich reading frame (9, 24). Both novel splice 
site mutations c.1373+2T>C in patient P22 and c.1373+1G>C in the 3 patients 
of family 21 change the donor splice site and are expected to lead to a loss 
of the generally used splice site. Choate et al. (9) described a mutation at the 
same position c.1373+1, but switching a G to an A. In patient P22, the initial 
diagnosis of autosomal recessive congenital ichthyosis (ARCI) was revised 
to CRIE at the age of 4 years, when the first revertant skin spots developed. 
In patient P21-1, the development of white spots escaped attention up to the 
age of 57 years, when diagnosis was made by an experienced dermatologist. 
Interestingly, this patient not only shows white spots, but has also developed 
patchy hyperpigmentation. Two of her children are also affected; like their 
mother, expression of CRIE is mild and resembles a mild to moderate type 
of congenital ichthyosiform erythroderma.
7Both mutations lead to an arginine-rich reading frame and a truncated protein, 
which is shortened by 4 amino acids compared with the wild-type protein 
(Fig. S11). The variable severity of the phenotypes could be explained by the 
position of the mutation and the number of altered amino acids, which change 
protein function to different extents. However, other genetic or epigenetic 
factors may also influence the disease severity.
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KRT10, which lead to CRIE, are deletions or duplications 
in exon 7 or splice site mutations at the acceptor splice 
site of exon 6 or the donor splice site of exon 7. It has 
been suggested that the dominant KRT10 mutations in 
CRIE result in an arginine-rich C-terminal frameshift 
leading to a mislocalization of the protein to the nucleus, 
which would impair the normal function of the keratin 
network (9, 26). The novel mutations c.1411_1412insA 
and c.1544dupG also result in an arginine-rich reading 
frame and a premature stop codon. Intriguingly, our novel 
mutation c.1544delG does not lead to an arginine-rich 
reading frame, but to an alanine-rich reading frame and 
an elongated protein (Fig. S11). Frameshift mutations in 
KRT10, which produce an alanine-rich reading frame 
have not been reported previously. Unfortunately, for 
technical reasons, immunofluorescence K10 staining in 
skin biopsies of this patient could not be performed, so 
we were unable to evaluate whether this mutation also 
causes an accumulation of K10 in the nucleus. Our fin-
dings suggest that an arginine-rich C-terminal peptide is 
not required for the development of the CRIE phenotype, 
and other factors may play a role in pathogenesis. Further 
functional studies are needed to determine the pathogenic 
mechanisms that lead to mitotic recombination. 
Recently, Choate et al. (10) described a patient with a 
CRIE-like phenotype in whom they found a frameshift 
mutation in KRT1 (c.1866insG, p.Val622Cysfs*30). 
This patient’s first confetti-like spots appeared at the age 
of 22 years with a maximum size of 4 mm. His skin sho-
wed no parakeratosis, milder perinuclear vacuolization 
and prominent coarse keratohyalin granules. This is in 
contrast to CRIE patients with KRT10 mutations, whose 
confetti-like spots typically appear early in childhood 
and reach a size of up to 2 cm and whose skin reveals 
parakeratosis, pronounced perinuclear vacuolization 
and absent keratohyalin granules (9, 10). Milder forms 
of CRIE can also occur in patients with mutations in 
KRT10. In family 21, the mother (P21-1) was diag-
nosed with CRIE at age 57 years, and the diagnostic 
significance of her white spots escaped attention up to 
this age. Two children (P21-2, P21-3) from this family 
are also affected with a mild form of CRIE, resembling 
a mild to moderate type of congenital ichthyosiform 
erythroderma. The mutation c.1866insG leads to the 
same reading frame as in previously reported patients 
with mutations in KRT1 showing mild ichthyosis hystrix 
Curth-Macklin (c.1861insT) (27) and mild EI without 
skin fragility (c.1757dupG) (28). Patient P10 with EI, 
who carries the mutation c.1752dupT in KRT1, shows 
the same reading frame (Fig. S11). Frameshift mutations 
in KRT1 can therefore lead to very different phenotypes.
The genotype-phenotype correlations in SEI, EI and 
CRIE are very complex. The differential diagnosis 
between these diseases can be difficult, since the pheno-
types can vary in severity. In some of our patients who 
were first suspected to have EI and to carry mutations in 
KRT1 or KRT10, we found mutations in KRT2. Conver-
sely, patients with suspected SEI sometimes exhibited 
a mild EI phenotype and carried a mutation in KRT1 or 
KRT10. Therefore, in patients with suspected SEI or EI, 
in which no mutation in the corresponding genes can be 
found, analysis of other keratin genes could be useful8.
The type and position of KRT10 mutations can provide 
information regarding the correct clinical diagnosis EI or 
CRIE, since CRIE mutations are deletions, duplications 
or splice site mutations in exon 7 and flanking introns, 
whereas EI mutations are substitutions in exons 1 or 6. 
Immunofluorescence staining for keratin 10 is another 
possibility for early diagnosis of CRIE, since nuclear 
staining for keratin 10 has been described only in CRIE 
and might be considered as a diagnostic hallmark (24). 
Clinical features, which were consistently associated 
with CRIE, can be defined as major criteria, whereas 
features, which are not obligatory present in patients, can 
be defined as minor criteria (25, 26). Several previously 
described features in patients with CRIE are consistent 
with our findings, such as growth retardation (P23–P25), 
palmoplantar keratoderma (P23, P25), hypertrichosis 
(P26), ectropion (P23, P24), hypoplasia of mammillae 
(agenesia of nipples in P23), scalp hair loss (alopecia 
totalis in P24) malformations of the nails (onycho-
dystrophy in P23), joint contractions (P24), hyperpig-
mentation (P21-1), decreased finger length (shortened 
fingers and toes in P25) (24, 25, 26). To our knowledge, 
some clinical findings that we have found in our cohort 
have not been described previously in patients with 
this disease. These include malposition of 4th toe (P23, 
P25), spasticity (P23), facial dysmorphisms (P23, P25), 
symblepharon (P25) and mental retardation (P23, P25). 
However, psychomotor retardation has been described in 
a 2-year-old patient with CRIE who carries the mutation 
c.1383_1414del32 in KRT10 (24). These features can be 
added to the list of minor features in CRIE. 
In conclusion, the findings of this study expand the 
clinical and mutational spectrum and genotype-phenotype 
correlation associated with SEI, EI and CRIE by descri-
bing 26 families and 8 novel pathogenic alterations. We 
describe here the first case of a patient with CRIE with a 
8This large variation in phenotype can even occur in patients with the same 
mutation. For example, the mutation c.1434G>T, p.Glu478Asp in KRT1 
has been reported previously in patients from Japan and Korea (16–18). 
Patients described in these publications showed a very mild phenotype and 
had similar clinicopathological features to SEI. The mutation p.Glu478Asp 
does not lead to a change in side-chain polarity, in contrast to the mutations 
p.Glu478Gln and p.Glu478Lys, which change polarity and lead to more severe 
phenotypes. Sung et al. (18) postulated that the polarity of the substituted 
amino acid can influence the phenotypic severity of EI. Indeed, patient 
P7, who carries the p.Glu478Asp mutation, showed a mild generalized 
ichthyosis. However, from the clinical point of view his adult phenotype 
could be classified as palmoplantar keratoderma with mild ichthyosis. The 
large variation in phenotypes in patients even with the same mutation suggests 
that other genetic or epigenetic factors, as well as environmental factors, may 
significantly influence the severity of the disease.
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mutation in KRT10, which does not lead to an arginine-
rich reading frame. Further functional studies are neces-
sary to elucidate the pathogenic mechanisms involved.
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